4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Citrinin/AG-CN2-0101-M025/25 mg
商品详细Adipogen/Citrinin/AG-CN2-0101-M025/25 mg
Adipogen/Citrinin/AG-CN2-0101-M025/25 mg
Adipogen/Citrinin/AG-CN2-0101-M025/25 mg
商品编号: AG-CN2-0101-M025
品牌: Adipogen Inc
市场价: ¥7200.00
美元价: 4320.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
More Information
Product Details
Synonyms NSC 186; BRN 0088597; Antimycin
Product Type Chemical
Properties
Formula C13H14O5
MW 250.3
Merck Index 14: 2327
CAS 518-75-2
RTECS DJ2275000
Source/Host Chemicals Isolated from Penicillium citrinum strain FKI-4836.
Purity Chemicals ≥97% (HPLC)
Appearance Yellow solid.
Solubility Soluble in methanol, ethanol, methylene chloride, pyridine or dioxane. Insoluble in water, chloroform or hexane.
Declaration Manufactured by BioLinks K.K. with courtesy strain from The Kitasato Institute.
Other Product Data Solutions change color with changes in pH from yellow (pH 4.6) to red (pH 9.9).
InChi Key CQIUKKVOEOPUDV-IYSWYEEDSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After reconstitution, prepare aliquots and store at -20°C.
Use/Stability Stable for at least 3 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
  • Antibiotic [1, 2].
  • Antiprotozoal. Antimicrobial [3, 6].
  • Cytotoxic and genotoxic in various mammalian cells [4].
  • Mitochondrial permeability transition pore (MPTP) activator [5-7].
  • Apoptosis inducer [7-9, 14].
  • ERK and JNK signaling pathways activator [10].
  • Nephrotoxic mycotoxin [11].
  • Suppresses NO and iNOS expression via inhibition of the JAK/STAT-1α and NF-κB signaling pathways [12].
  • Tubulin polymerization and mitotic spindle assembly inhibitor [13].
  • Increases reactive oxygen species (ROS) [14].
  • Induces cell cycle arrest at the G0/G1 and G2/M phase [13,14].
Product References
  1. Citrinin: T.S. Gore, et al.; Nature 16, 157 (1946)
  2. Citrinin as an Antibiotic: Y. Wang, et al.; Science 106, 291 (1947)
  3. Antiprotozoal activity in citrinin: A.W. Hayes, et al.; Bull. Environ. Contam. Toxicol. 15, 429 (1976)
  4. Cytotoxicity of citrinin in cultured kidney epithelial cell systems: M. Yoneyama, et al.; Ecotoxicol. Environ. Saf. 11, 100 (1986)
  5. Citrinin-induced mitochondrial permeability transition: E.J. Da Lozzo, et al.; J. Biochem. Mol. Toxicol. 12, 291 (1998)
  6. Antimicrobial activity of the mycotoxin citrinin obtained from the fungus penicillium citrinum: P.M. Mazumder, et al.; Anc. Sci. Life. 21, 191 (2002)
  7. Citrinin induces apoptosis in HL-60 cells via activation of the mitochondrial pathway: F.Y. Yu, et al.; Toxicol. Lett. 161, 143 (2006)
  8. Citrinin induces apoptosis via a mitochondria-dependent pathway and inhibition of survival signals in embryonic stem cells, and causes developmental injury in blastocysts: W.H. Chan; Biochem. J. 404, 317 (2007)
  9. Citrinin induces apoptosis in mouse embryonic stem cells: W.H. Chan; IUBMB Life 60, 171 (2008) (Review)
  10. Activation of ERK and JNK signaling pathways by mycotoxin citrinin in human cells: C.H. Chang, et al.; Toxicol. Appl. Pharmacol. 237, 281 (2009)
  11. Toxicological properties of citrinin: D. Flajs & M. Peraica; Arh. Hig. Rada Toksikol. 60, 457 (2009) (Review)
  12. The fungal metabolite, citrinin, inhibits lipopolysaccharide/interferon-γ-induced nitric oxide production in glomerular mesangial cells: B.H. Liu, et al.; Int. Immunopharmacol. 10, 1608 (2010)
  13. Mycotoxin citrinin induced cell cycle G2/M arrest and numerical chromosomal aberration associated with disruption of microtubule formation in human cells: C.H. Chang, et al.; Toxicol. Sci. 119, 84 (2011)
  14. Citrinin-generated reactive oxygen species cause cell cycle arrest leading to apoptosis via the intrinsic mitochondrial pathway in mouse skin: R. Kumar, et al.; Toxicol. Sci. 122, 557 (2011)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。